Clinical trial
A Study to Evaluate the Efficacy and Safety of ZILRETTA in Subjects With Glenohumeral Osteoarthritis
NCT06269705 is registered in ClinicalTrials.gov with Pacira Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Efficacy and Safety of ZILRETTA in Subjects With Glenohumeral Osteoarthritis
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- February 5, 2024
- Completion date
- December 31, 2026
- Enrollment
- 150 (estimated)
- Sites
- 32
Conditions
As the registry lists them; a condition with its own page is linked.
glenohumeral osteoarthritis